Gremlin-1 antibody
    64.
    发明授权

    公开(公告)号:US10947304B2

    公开(公告)日:2021-03-16

    申请号:US16470996

    申请日:2017-12-19

    申请人: UCB BIOPHARMA SRL

    摘要: This invention relates to crystals of the human Gremlin-1 protein, and the human Gremlin-1 protein in complex with an inhibitory antibody. The invention also relates to the structure of human Gremlin-1 (on its own, or in complex with the antibody) and uses of these structures in screening for agents which modulate Gremlin-1 activity. The invention further provides antibodies which bind an allosteric inhibitory site on Gremlin-1, together with pharmaceutical compositions and medical uses of such antibodies and agents identified by the screening methods.

    Obtaining an Improved Therapeutic Ligand

    公开(公告)号:US20210005277A1

    公开(公告)日:2021-01-07

    申请号:US16823055

    申请日:2020-03-18

    申请人: UCB Biopharma SRL

    摘要: Methods and associated apparatus involving designing a ligand ab initio that will bind to a binding site of a macromolecular target, or of identifying a modification to a ligand for improving the affinity of the ligand to a binding site of a macromolecular target, comprising using information about non-bonding, intra-molecular or inter-molecular atom to atom contacts extracted from a database of biological macromolecules to identify favoured regions adjacent to the binding site for particular atom types and modifying a candidate ligand to increase the intersection between atoms of the candidate ligand and the favoured regions. One or more steps of the methods may be performed by a computer.

    CHROMATOGRAPHY
    67.
    发明申请
    CHROMATOGRAPHY 审中-公开

    公开(公告)号:US20200331960A1

    公开(公告)日:2020-10-22

    申请号:US16629609

    申请日:2018-07-16

    申请人: UCB BIOPHARMA SRL

    摘要: The present invention is in the field of purification and protein purification in particular. The invention provides improved techniques for the industrial-scale purification of proteins and other biomolecules. More specifically, it relates to a process for the purification of a compound of interest, such as a protein, preferably an antibody or an antibody fragment using a chromatography step, preferably a semi-continuous chromatography step.